Home Cart Sign in  
Chemical Structure| 4373-41-5 Chemical Structure| 4373-41-5

Structure of Maslinic acid
CAS No.: 4373-41-5

Chemical Structure| 4373-41-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Maslinic Acid is a byproduct of olive oil extraction exhibiting antiproliferative effect.

Synonyms: 2α-Hydroxyoleanolic acid; Crategolic acid; 2α-Hydroxyoleanoic Acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Maslinic acid

CAS No. :4373-41-5
Formula : C30H48O4
M.W : 472.70
SMILES Code : C[C@]([C@@]1([H])[C@]2(C[C@@H](O)[C@@H]3O)C)(CC[C@@]2([H])C3(C)C)[C@@](C4=CC1)(CC[C@]5(C(O)=O)[C@@]4([H])CC(C)(C)CC5)C
Synonyms :
2α-Hydroxyoleanolic acid; Crategolic acid; 2α-Hydroxyoleanoic Acid
MDL No. :MFCD00049293
InChI Key :MDZKJHQSJHYOHJ-LLICELPBSA-N
Pubchem ID :73659

Safety of Maslinic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Maslinic acid

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human umbilical vein endothelial cells (HUVECs) 2–20 μM 6 hours MA suppressed LPS-induced COX-2 and iNOS expression, reduced PGE2 and NO production, and upregulated HO-1 expression Antioxidants (Basel). 2020 Jan 25;9(2):106

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LPS-induced lung injury model Intravenous injection 0.07–0.7 mg/kg Single dose, observed for 1 day MA significantly downregulated iNOS expression in lung tissue and TNF-α levels in bronchoalveolar lavage fluid, and alleviated LPS-induced lung tissue injury Antioxidants (Basel). 2020 Jan 25;9(2):106
ICR mice Cognitive dysfunction model induced by cholinergic blockade Oral 0.3, 1 or 3 mg/kg Administered 1 hr before behavioral tests Maslinic acid enhances cognitive function through the activation of BDNF and its downstream pathway signalling in the hippocampus, suggesting its potential as a therapeutic agent for cognitive decline such as in AD. Br J Pharmacol. 2020 Jul;177(14):3197-3209

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02520739 Cardiovascular Diseases Phase 3 Unknown December 2016 Spain ... More >> University Hospital Virgen de las Nieves Granada, Spain, 18012 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.12mL

0.42mL

0.21mL

10.58mL

2.12mL

1.06mL

21.16mL

4.23mL

2.12mL

References

 

Historical Records

Categories